Cara Therapeutics, Inc. 4
4 · Cara Therapeutics, Inc. · Filed Feb 19, 2015
Insider Transaction Report
Form 4
Schoell Josef
Chief Financial Officer
Transactions
- Sale
Common Stock
2015-02-17$10.96/sh−15,000$164,400→ 25,000 total
Footnotes (2)
- [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 10, 2014.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.91 - $11.02, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4.